Do the effects of pentoxifylline on the inflammatory process and pancreatic infection justify its use in acute pancreatitis?

Pancreatology

Volumn 9, Issue 5, 2009, Pages 687-693

  Matheus, Andre Siqueira ^a   Coelho, Ana Maria M ^a   Sampietre, Sandra ^a   Jukemura, Jose ^a   Patzina, Rosely A ^a   Cunha, Jose Eduardo Monteiro ^a   MacHado, Marcel Cerqueira Cesar ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute pancreatitis; Inflammatory process; Pancreatic infection; Pentoxifylline; TNF

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; PENTOXIFYLLINE; SODIUM CHLORIDE; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; BACTERIUM CULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; HISTOLOGY; INFECTION; INFLAMMATION; MALE; MORTALITY; NONHUMAN; PANCREAS INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SHAM PROCEDURE; WISTAR RAT;

EID: 68549085396     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000199438     Document Type: Article

References (43)

1. Beger HG, Rau B, Mayer J, Pralle U: Natural course of acute pancreatitis. World J Surg 1997; 21: 130-135.
2. Isenmann R, Rau B, Zoellner U, Beger HG: Management of patients with extended pancreatic necrosis. Pancreatology 2001; 1: 63-68.
3. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P, Chevali L: Pathophysiology of acute pancreatitis. Pancreatology 2005; 5: 132-144.
4. Sakorafas GH, Tsiotou AG: Etiology and pathogenesis of acute pancreatitis: current concepts. J Clin Gastroenterol 2000; 30: 343-356.
5. Bettinger JR, Grendell JH: Intracellular events in the pathogenesis of acute pancreatitis. Pancreas 1991; 6: 2-6.
6. Bhatia M, Brady M, Shokuhi S, Christmas S, Neoptolemos JP, Slavin J: Inflammatory mediators in acute pancreatitis. J Pathol 2000; 190: 117-125.
7. Makhija R, Kingsnorth NA: Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002; 9: 401-410.
8. Raraty MG, Connor S, Criddle DN, Sutton R, Neoptolemos JP: Acute pancreatitis and organ failure: pathophysiology, natural history, and management strategies. Curr Gastroenterol Rep 2004; 6: 99-103.
9. Isenmann R, Beger HG: Bacterial infection of pancreatic necrosis: role of bacterial translocation, impact of antibiotic treatment. Pancreatology 2001; 1: 79-89.
10. Ward A, Clissold SP: Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987; 34: 50-97. (Pubitemid 17092322)
11. Huh PW, Kotasek D, Jacob HS, Vercellotti GM, Hammerschmidt DE: Mechanism of action of pentoxifylline in peripheral vascular disease: inhibition of platelet and granulocyte responsiveness. Clin Res 1985; 33: 866-878.
12. Dorizil-Dudzik M, Mika J, Schafer MK, Li Y, Obara I, Wordliczek J, Przewlocka B: The effects of local pentoxifylline and propentoxifylline treatment on formalin-induced pain and tumor necrosis factor-alpha messenger RNA levels in inflamed tissue of the rat paw. Anesth Analg 2004; 98: 1566-1573.
13. Ji Q, Zhang L, Jia H, Xu J: Pentoxifylline inhibits endotoxin-induced NF-kappa B activation and associated production of proinflammatory cytokines. Ann Clin Lab Sci 2004; 34: 427-436.
14. Gomez-Cambronero L, Camps B, de La Asuncion JG, Cerda M, Pellin A, Pallardo FV, Calvete J, Sweiry JH, Mann GE, Vina J, Sastre J: Pentoxifylline ameliorates ceruleininduced pancreatitis in rats: role of glutathione and nitric oxide. J Pharmacol Exp Ther 2000; 293: 670-676.
15. Lankisch PG, Koop H, Winckler K, Folsch UR, Creutzfeldt W: Somatostatin therapy of acute experimental pancreatitis. Gut 1977; 18: 713-716.
16. Storck G: Fat necrosis in acute pancreatitis. Morphological and chemical studies in the rat. Acta Chir Scand 1971; 417: 1-36.
17. Machado MC, Coelho AM, Pontieri V, Sampietre SN, Molan NA, Soriano F, Matheus AS, Patzina RA, Cunha JE, Velasco IT: Local and systemic effects of hypertonic solution (NaCl 7.5%) in experimental acute pancreatitis. Pancreas 2006; 32: 80-86.
18. Matheus AS, Coelho AM, Sampietre S, Patzina R, Jukemura J, Cunha JE, Machado MC: Effect of inhibition of prostaglandin E 2 production on pancreatic infection in experimental acute pancreatitis. HPB 2007; 9: 392-397.
19. Michetti C, Coimbra R, Hoyt DB, Loomis W, Junger W, Wolf P: Pentoxifylline reduces acute lung injury in chronic endotoxemia. J Surg Res 2003; 115: 92-99.
20. Coimbra R, Melbostad H, Loomis W, Porcides RD, Wolf P, Tobar M, Hoyt DB: LPSinduced acute lung injury is attenuated by phosphodiesterase inhibition: effects on proinflammatory mediators, metalloproteinases, NF-kappaB, and ICAM-1 expression. J Trauma 2006; 60: 115-125.
21. Coimbra R, Porcides R, Loomis W, Melbostad H, Lall R, Deree J, Wolf P, Hoyt DB: HSPTX protects against hemorrhagic shock resuscitation-induced tissue injury: an attractive alternative to Ringer's lactate. J Trauma 2006; 60: 41-51.
22. Grewal HP, Kotb M, el Din AM, Ohman M, Salem A, Gaber L, Gaber AO: Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 1994; 115: 213-221.
23. Dolan SJ, Lewis H, McCluggage C, Halliday MI, Rowlands BJ: Systemic endotoxin, antiendotoxin antibodies, and proinflammatory cytokines in the taurocholate model of acute pancreatitis. HPB 1999; 4: 71-77.
24. Schmidt J, Rattner DW, Lewandrowski R, Compton CC, Mandavilli U, Knofel WT, Warshaw AL: A better model of acute pancreatitis for evaluating therapy. Ann Surg 1992; 215: 44-56.
25. Mayer J, Rau B, Gansauge F, Beger HG: Inflammatory mediators in human acute pancreatitis: clinical and pathophysiology implications. Gut 2000; 47: 546-552.
26. Hirota M, Nozawa F, Okabe A, Shibata M, Beppu T, Shimada S, Egami H, Yamaguchi Y, Ikei S, Okajima T, Okamoto K, Ogawa M: Relationship between plasma cytokine concentration and multiple organ failure in patients with acute pancreatitis. Pancreas 2000; 21: 141-146.
27. Bhatia M, Neoptolemos JP, Slavin J: Inflammatory mediators as therapeutic targets in acute pancreatitis. Curr Opin Invest Drugs 2001; 2: 496-501.
28. Brivet FG, Emilie D: Predictive value of cytokines during acute severe pancreatitis. Crit Care Med 2000; 28: 2673.
29. Pooran N, Indaram A, Singh P, Bank S: Cytokines (IL-6, IL-8, TNF): early and reliable predictors of severe acute pancreatitis. J Clin Gastroenterol 2003; 37: 263-266.
30. Reber HA: Pathogenesis of infection in pancreatic inflammatory disease. Pancreatology 2001; 1: 207-209.
31. Samuel S, Lanig S, Lux A, Keese M, Gretz N, Nichterlein T, Sturn J, Lohr M, Post S: The gut origin of bacterial pancreatic infection during acute experimental pancreatitis in rats. Pancreatology 2002; 2: 449-455.
32. Foitzik T: The enteral factor in pancreatic infection. Pancreatology 2001; 1: 217-223.
33. Wittel UA, Wiech T, Chakraborty S, Boss B, Lauch R, Batra SK, Hopt UT: Taurocholateinduced pancreatitis: a model of severe necrotizing pancreatitis in mice. Pancreas 2008; 36: 9-21.
34. Souza LJ, Sampietre SN, Figueiredo S, Yria Y, Machado MC, Pinotti HW: Bacterial translocation in acute pancreatitis. Experimental study in rats. Rev Hosp Clin Fac Med Sao Paulo 1996; 51: 116-120.
35. Hughes CB, Gaber LW, Mohey el-Din AB, Grewal HP, Kotb M, Mann L, Gaber AO: Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis. Am Surg 1996; 62: 8-13.
36. Grewal HP, Mohey el Din A, Gaber L, Kotb M, Gaber AO: Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody. Am J Surg 1994; 167: 214-218.
37. Marton J, Farkas G, Takacs T, Nagy Z, Szasz Z, Varga J, Jarmay K, Balogh A, Lonovics J: Beneficial effects of pentoxifylline treatment of experimental acute pancreatitis in rats. Res Exp Med 1998; 197: 293-299. (Pubitemid 28143736)
38. Oruc N, Ozutemiz AO, Yukselen V, Nart D, Celik HA, Yuce G, Batur Y: Infliximab: a new therapeutic agent in acute pancreatitis? Pancreas 2004; 28: 1-8.
39. Siegel CA, Hur C, Korzenik JR, Gazelle GS, Sands BE: Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol 2006; 4: 1017-1024.
40. Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP: Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc 2008; 83: 181-194.
41. Branten AJ: Risk of infectious complications during anti-TNFalpha therapy. Neth J Med 2008; 66: 50-52.
42. Pereda J, Sabater L, Cassinello N, Gomez- Cambronero L, Closa D, Folch-Puy E, Aparisi L, Calvete J, Cerda M, Lledo S, Vina J, Sastre J: Effect of simultaneous inhibition of TNF-alpha production and xanthine oxidase in experimental acute pancreatitis: the role of mitogen activated protein kinases. Ann Surg 2004; 240: 108-116.
43. Souza LJ, Sampietre SN, Assis RS, Knowles CH, Leite KRM, Jancar S, Cunha JEM, Machado MCC: Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis. J Gastrointest Surg 2001; 5: 364-370.